IBA moves toward sale of Cisbio Bioassays

05/14/2013 | Reuters

Ion Beam Applications said it is in a tentative deal to sell its drug discovery unit Cisbio Bioassays to a private equity firm in Europe for $32.5 million. IBA said it is focusing on its core operations involving particle accelerators and radiation therapy. The deal is set to be completed in the coming months.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA